Vet Med - Czech, 2016, 61(10):571-576 | DOI: 10.17221/159/2015-VETMED

Decrease in C-reactive protein levels in rabbits after vaccination with a live attenuated myxoma virus vaccineOriginal Paper

L. Ondruska1, V. Parkanyi1, J. Vasicek1, R. Jurcik1, E. Hanusova1, D. Vasicek1, A. Balazi1, F. Vizzarri2
1 National Agricultural and Food Centre, Research Institute for Animal Production Nitra, Luzianky, Slovak Republic
2 University of Molise, Campobasso, Italy

The aim of this study was to evaluate the acute phase reaction and immune response of rabbits triggered by vaccination with a live attenuated myxoma virus (MXT) vaccine. Thirteen adult and 11 juvenile New Zealand white rabbit-based crossbreed rabbits, were used. Samples of rabbit peripheral blood were collected from vena auricularis centralis into heparinised tubes before vaccination and 48 h after vaccination. All animals were vaccinated by subcutaneous injection (0.5 ml) with a MXT vaccine. The blood plasma C-reactive protein level was measured by an ELISA kit using a double-antibody sandwich. For phenotyping of lymphocytes the fresh cells were stained with the following anti-rabbit monoclonal antibodies: anti-IgM, anti-CD4, anti-CD8 and anti-pan T2. Our results show that the use of attenuated myxoma virus vaccine significantly decreases the level of C-reactive protein in blood plasma of adult rabbits by 38.14% (P < 0.05) and of juvenile rabbits by 37.63% (P < 0.001), within 48 h. The rabbit C-reactive protein after MXT vaccination is a negative acute phase protein. In the group of adult rabbits the immune response to MXT vaccination was accompanied by a non-significant decrease in CD4+, pT2+, IgM+ subsets. On the other hand the values of CD8+, CD4+CD8+ and CD4+/CD8+ were non-significantly higher after MXT vaccination.

Keywords: rabbit; Oryctolagus cuniculus; myxomatosis; ELISA

Published: October 31, 2016  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Ondruska L, Parkanyi V, Vasicek J, Jurcik R, Hanusova E, Vasicek D, et al.. Decrease in C-reactive protein levels in rabbits after vaccination with a live attenuated myxoma virus vaccine. Vet Med - Czech. 2016;61(10):571-576. doi: 10.17221/159/2015-VETMED.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Barry M, Lee SF, Boshkov L, McFadden G (1995): Myxoma virus induces extensive CD4 downregulation and dissociation of p56lck in infected rabbit CD41 T lymphocytes. Journal of Virology 69, 5243-5251. Go to original source... Go to PubMed...
    2. Best SM, Kerr PJ (2000): Coevolution of host and virus: the pathogenesis of virulent and attenuated strains of myxoma virus in resistant and susceptible European rabbits. Virology 267, 36-47. Go to original source... Go to PubMed...
    3. Brahn E, Lee S, Lucas AR, McFadden G, Macaulay C (2014): Suppression of collagen-induced arthritis with a serine proteinase inhibitor (serpin) derived from myxoma virus. Clinical Immunology 153, 254-263. Go to original source... Go to PubMed...
    4. Destexhe E, Prinsen MK, van Scholl I, Kuper FC, Garcon N, Veenstra S, Segal L (2013): Evaluation of C-reactive protein as an inflammatory biomarker in rabbits for vaccine nonclinical safety studies. Journal of Pharmacological and Toxicological Methods 68, 367-373. Go to original source... Go to PubMed...
    5. Du Clos TW, Mold C (2003): 3 C-reactive protein: structure, synthesis and function. In: Wong S, Arsequell G (eds): Immunobiology of Carbohydrates. Kluwer Academic/ Plenum Publishers, New York. 47-61.
    6. Faldyna M, Leva L, Knotigova P, Toman M (2001): Lymphocyte subsets in peripheral blood of dogs - a flow cytometric study. Veterinary Immunology and Immunopathology 82, 23-37. Go to original source... Go to PubMed...
    7. Finkelman FD, Holmes J, Katona IM, Urban Jr JF, Beckmann MP, Park LS, Schooley KA, Coffman RL, Mosmann TR, Paul WE (1990): Lymphokine control of in vivo immunoglobulin isotype selection. Annual Review of Immunology 8, 303-333. Go to original source... Go to PubMed...
    8. Gabay C, Kushner I (1990): Acute phase proteins and other systemic responses to inflammation. New England Journal of Medicine 340, 448-454. Go to original source... Go to PubMed...
    9. Jackson RJ, Hall DF, Kerr PJ (1999): Myxoma virus encodes an alpha 2,3-sialyltransferase that enhances virulence. Journal of Virology 73, 2376-2384. Go to original source... Go to PubMed...
    10. Jain S, Gautam V, Naseem S (2011): Acute phase proteins: As diagnostic tool. Journal of Pharmacy and Bioallied Sciences 3, 118-127. Go to original source... Go to PubMed...
    11. Jeklova E, Leva L, Faldyna M (2007): Lymphoid organ development in rabbits: Major lymphocyte subsets. Developmental and Comparative Immunology 31, 632-644. Go to original source... Go to PubMed...
    12. Jeklova E, Leva L, Matiasovic J, Kovarcik K, Kudlackova H, Nevorankova Z, Psikal I, Faldyna M (2008): Characterisation of immunosuppression in rabbits after infection with myxoma virus. Veterinary Microbiology 129, 117-130. Go to original source... Go to PubMed...
    13. Kelso A, Troutt AB, Maraskovsky E, Gough NM, Morris L, Pech MH, Thomson JA (1991): Heterogeneity in lymphokine profiles of CD4+ and CD8+ T cells and clones activated in vivo and in vitro. Immunological reviews 123, 85-113. Go to original source... Go to PubMed...
    14. Lanning D, Sethupathi P, Rhee KJ, Zhai SK, Knight KL (2000): Intestinal microflora and diversification of the rabbit anti-body repertoire. Journal of Immunology 165, 2012-2019. Go to original source... Go to PubMed...
    15. Lomas DA, Evans DL, Upton C, McFadden G, Carrell RW (1993): Inhibition of plasmin, urokinase, tissue plasminogen activator, and C1S by a myxoma virus serine proteinase inhibitor. Journal of Biological Chemistry 268, 516-521. Go to original source...
    16. McFadden G, Barry M (1998): How poxviruses oppose apoptosis. Seminars in Virology 8, 429-442. Go to original source...
    17. Messud-Petit F, Gelfi J, Delverdier M, Amardeilh MF, Py R, Sutter G, Bertagnoli S (1998): Serp2, an inhibitor of the interleukin-1β-converting enzyme, is critical in the pathobiology of myxoma virus. Journal of Virology 72, 7830-7839. Go to original source... Go to PubMed...
    18. Mosmann TR, Coffman RL (1989): Th1 and Th2 cells: different patterns of lymphokine secretion lead to different functional properties. Annual Review of Immunology 7, 145-173. Go to original source... Go to PubMed...
    19. Nash P, Whitty A, Handwerker J, Macen J, McFadden G (1998): Inhibitory specificity of the anti-inflammatory myxoma virus serpin SERP-1. Journal of Biological Chemistry 273, 20982-20991. Go to original source... Go to PubMed...
    20. Nash P, Barrett J, Cao JX, Hota-Mitchell S, Lalani AS, Everett H, Xu XM, Robichaud J, Hnatiuk S, Ainslie C (1999): Immunomodulation by viruses: the myxoma virus story. Immunological Reviews 168, 103-120. Go to original source... Go to PubMed...
    21. Nossal GJV (1997): Host immunobiology and vaccine development. The Lancet 350, 1316-1319. Go to original source... Go to PubMed...
    22. Petit F, Bertagnoli S, Gelfi J, Fassy F, Boucraut-Baralon C, Milon A (1996): Characterization of a myxoma virus-encoded serpin-like protein with activity against interleukin1β-converting enzyme. Journal of Virology 70, 5860-5866. Go to original source... Go to PubMed...
    23. Spiesschaert B, McFadden G, Hermans K, Nauwynck H, Van de Walle GR (2011): The current status and future directions of myxoma virus, a master in immune evasion. Veterinary Research 76, 1-18. Go to original source... Go to PubMed...
    24. Strayer DS (1992): Determinants of virus-related suppression of immune responses as observed during infection with an oncogenic poxvirus. Progress in Medical Virology 39, 228-255.
    25. Strayer DS, Skaletsky E, Leibowitz JL, Dombrowski J (1987): Growth of malignant rabbit fibroma virus in lymphoid cells. Virology 158, 147-157. Go to original source... Go to PubMed...
    26. Tokarz-Deptula B, Deptula W (2005): Values of selected immune and haematological parameters in healthy rabbits. Polish Journal of Veterinary Sciences 8, 107-112.
    27. Tothova C, Nagy O, Kovac G (2014): Acute phase proteins and their use in the diagnosis of diseases in ruminants: a review. Veterinarni Medicina 59, 163-180. Go to original source...
    28. Turner PC, Moyer RW (1998): Control of apoptosis by poxviruses. Seminars in Virology 8, 453-469. Go to original source...
    29. Vajdy M, Sethupathi P, Knight KL (1998): Dependence of antibody somatic diversification on gut-associated lymphoid tissue in rabbits. Journal of Immunology 160, 2725-2729. Go to original source...
    30. Watzinger M, Nguyen A, Gervais F, Lemarchand T, Legrand J, Descotes J (2011): Evaluation of inflammation biomarkers for safety assessment of vaccines and adjuvants in the rabbit. 47th Congress of the European Societies of Toxicology. Toxicology Letters 205, S113-S114. Go to original source...

    This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International (CC BY NC 4.0), which permits non-comercial use, distribution, and reproduction in any medium, provided the original publication is properly cited. No use, distribution or reproduction is permitted which does not comply with these terms.


    Return to the content